Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation.
Gaballa S, Palmisiano N, Alpdogan O, Carabasi M, Filicko-O'Hara J, Kasner M, Kraft WK, Leiby B, Martinez-Outschoorn U, O'Hara W, Pro B, Rudolph S, Sharma M, Wagner JL, Weiss M, Flomenberg N, Grosso D. Gaballa S, et al. Among authors: o hara w. Biol Blood Marrow Transplant. 2016 Jan;22(1):141-8. doi: 10.1016/j.bbmt.2015.09.017. Epub 2015 Sep 28. Biol Blood Marrow Transplant. 2016. PMID: 26415558 Free article. Clinical Trial.
A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing.
Grosso D, Carabasi M, Filicko-O'Hara J, Kasner M, Wagner JL, Colombe B, Cornett Farley P, O'Hara W, Flomenberg P, Werner-Wasik M, Brunner J, Mookerjee B, Hyslop T, Weiss M, Flomenberg N. Grosso D, et al. Blood. 2011 Oct 27;118(17):4732-9. doi: 10.1182/blood-2011-07-365338. Epub 2011 Aug 25. Blood. 2011. PMID: 21868572 Free article. Clinical Trial.
A two-step approach to myeloablative haploidentical transplantation: low nonrelapse mortality and high survival confirmed in patients with earlier stage disease.
Grosso D, Gaballa S, Alpdogan O, Carabasi M, Filicko-O'Hara J, Kasner M, Martinez-Outschoorn U, Wagner JL, O'Hara W, Rudolph S, Chervoneva I, Colombe B, Farley PC, Flomenberg P, Pro B, Sharma M, Shi W, Weiss M, Flomenberg N. Grosso D, et al. Biol Blood Marrow Transplant. 2015 Apr;21(4):646-52. doi: 10.1016/j.bbmt.2014.12.019. Epub 2014 Dec 23. Biol Blood Marrow Transplant. 2015. PMID: 25542159 Free article. Clinical Trial.
Autologous Stem Cell Transplantation for Multiple Myeloma: Growth Factor Matters.
Chen J, Pan J, Zhan T, Tuazon S, Saini N, O'Hara W, Filicko-O'Hara J, Klumpp T, Kasner M, Carabasi M, Porcu P, Wagner JL. Chen J, et al. Among authors: o hara w. Biol Blood Marrow Transplant. 2019 Sep;25(9):e293-e297. doi: 10.1016/j.bbmt.2019.05.035. Epub 2019 Jun 4. Biol Blood Marrow Transplant. 2019. PMID: 31173899 Free article.
The Presence of a CMV Immunodominant Allele in the Recipient Is Associated With Increased Survival in CMV Positive Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation.
Grosso D, Leiby B, Carabasi M, Filicko-O'Hara J, Gaballa S, O'Hara W, Wagner JL, Flomenberg N. Grosso D, et al. Among authors: o hara w. Front Oncol. 2019 Sep 17;9:888. doi: 10.3389/fonc.2019.00888. eCollection 2019. Front Oncol. 2019. PMID: 31608225 Free PMC article.
Low Nonrelapse Mortality after HLA-Matched Related 2-Step Hematopoietic Stem Cell Transplantation Using Cyclophosphamide for Graft-versus-Host Disease Prophylaxis and the Potential Impact of Non- Cyclophosphamide-Exposed T Cells on Outcomes.
Grosso D, Carabasi M, Filicko-O'Hara J, Wagner JL, O'Hara W, Sun M, Colombe B, Shi W, Werner-Wasik M, Rudolph S, Alpdogan O, Binder A, Kasner M, Klumpp T, Martinez-Outschoorn U, Palmisiano N, Wilde L, Porcu P, Gergis U, Flomenberg N. Grosso D, et al. Among authors: o hara w. Biol Blood Marrow Transplant. 2020 Oct;26(10):1861-1867. doi: 10.1016/j.bbmt.2020.06.021. Epub 2020 Jul 3. Biol Blood Marrow Transplant. 2020. PMID: 32629157 Free article.
An Examination of Cytomegalovirus, Socioeconomic Status, Race, and Ethnicity on Outcomes after Haploidentical Hematopoietic Transplantation.
Jeurkar C, Leiby B, Banks J, Leader A, Rudolph S, Mateja G, Rashid SA, Carabasi M, Filicko-O'Hara J, O'Hara W, Wagner JL, Gergis U, Flomenberg N, Grosso D. Jeurkar C, et al. Among authors: o hara w. Transplant Cell Ther. 2021 Apr;27(4):327.e1-327.e11. doi: 10.1016/j.jtct.2020.11.017. Epub 2020 Dec 16. Transplant Cell Ther. 2021. PMID: 33836876 Free article.
The Two-Step Allogeneic Stem Cell Transplantation Approach Results in Rapid Engraftment and Excellent Outcomes in Patients with Lymphoid Malignancies.
Yang Y, Gergis U, Carabasi M, Filicko-O'Hara J, Wagner JL, O'Hara W, Binder A, Alpdogan O, Martinez-Outschoorn U, Porcu P, Flomenberg N, Grosso D. Yang Y, et al. Among authors: o hara w. Transplant Cell Ther. 2022 Mar;28(3):159.e1-159.e5. doi: 10.1016/j.jtct.2021.12.013. Epub 2021 Dec 24. Transplant Cell Ther. 2022. PMID: 34954295 Free article.
A Prospective, Randomized Trial Examining the Use of G-CSF Versus No G-CSF in Patients Post-Autologous Transplantation.
Grosso D, Leiby B, Wilde L, Carabasi M, Filicko-O'Hara J, O'Hara W, Wagner JL, Mateja G, Alpdogan O, Binder A, Kasner M, Keiffer G, Klumpp T, Martinez UO, Palmisiano N, Porcu P, Gergis U, Flomenberg N. Grosso D, et al. Among authors: o hara w. Transplant Cell Ther. 2022 Dec;28(12):831.e1-831.e7. doi: 10.1016/j.jtct.2022.09.012. Epub 2022 Sep 24. Transplant Cell Ther. 2022. PMID: 36167307 Free article. Clinical Trial.
28 results